BioLineRx (BLRX) Tops Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts BLRX Hot Sheet
Join SI Premium – FREE
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of $0.00, $0.08 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $430 thousand versus the consensus estimate of $4.62 million.
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet Sees FY26 Capex $195B To $205B, Saw $180B To $190B
- Jefferies Downgrades Henry Boot Plc (BOOT:LN) to Hold
- JPMorgan Upgrades Yantai Jereh Oilfield Services Group (002353:CH) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
